CellaVision AB (publ) (STO:CEVI)

Sweden · Delayed Price · Currency is SEK

156.20

-1.00 (-0.64%)

At close: Dec 5, 2025

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Americas Revenue	271.42M	268.56M	Log In	Log In	Log In	Upgrade
EMEA Revenue	345.29M	334.27M	Log In	Log In	Log In	Upgrade
APAC Revenue	131.75M	120.38M	Log In	Log In	Log In	Upgrade

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Instruments Revenue	419.85M	407.17M	Log In	Log In	Log In	Upgrade
Reagents Revenue	149.59M	140.54M	Log In	Log In	Log In	Upgrade
Software & Other Revenue	179.01M	175.50M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2012 - 2019
Organic Growth	7.00%	Log In	Log In	Log In	Upgrade